Approved comparison material connected to this topic.
3 total recordsSource comparisons are presented without a generated winner.
Primary Target Restores pulsatile GH secretion to reduce visceral adipose tissue and improve insulin sensitivity Elevates serum testosterone to address hypogonadal symptoms (libido, mood, energy, muscle mainte…
| Study | Population | Dose | Duration | Visceral Fat Reduction | Lean Mass Change | Key Findings ||—|—|—|—|—|—|| Falutz et al. (2010) The Lancet | HIV-associated lipodystrophy, men and women | 2mg daily | 26 …
Tesamorelin 2mg daily GHRH receptor agonist. Stimulates endogenous pulsatile GH release 15–18% reduction in VAT (Phase 3 data) High. Preserves nitrogen balance and amino acid uptake $400–$700 (research-grade c…